InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: James salmon post# 3190

Friday, 10/17/2014 6:50:12 PM

Friday, October 17, 2014 6:50:12 PM

Post# of 108192
Could we be getting lift off finally, James? smile

Aduro signs another big deal. Same technology as Advaxis but different platform.



Like Ford and GM have different platforms? smile

Aduro and ADXS have intellectual property founders who were collaborators on listeria-based vaccine development at Pennsylvania University.

The pair have gone different ways since but the foundation is the same.

Aduro...has attracted close attention for its use of a failed cancer vaccine--GVAX



GVAX, another in a long line failed allogeneic vaccines [vaccines made from cultured cancer cells as opposed to autologous - self-cancer - vaccines] was so predictable a failure that even this amateur predicted it.

It would be very foolish to deny the possibility of some adjuvant effect from another version of GVAX but I wouldn't bet a billion on it. Of course no one would ever be silly enough to give me a billion... smile

Very oddly, J&J has a history of making bad sidebets despite its enormous success in its core businesses.

Venerable Wall Street Maxim: "Those who buy don't read. Those who read don't buy."

Best, Terry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News